Calificación de consenso1
Buy
Precio objetivo más alto1
$310.00
Precio objetivo más bajo1
$167.00
Precio objetivo consensuado1
$236.06
Charles River Laboratories International Inc tiene un precio objetivo de consenso de $236.06 basado en las calificaciones de 22 analistas. El máximo es $310, emitido por JP Morgan el agosto 6, 2026. El mínimo es $167, emitido por CLSA el octubre 23, 2024. Las 3 calificaciones de analistas más recientes fueron publicadas por TD Cowen, Morgan Stanley y RBC Capital el agosto 10, 2026, agosto 7, 2026 y agosto 6, 2026, respectivamente. Con un precio objetivo promedio de $294 entre TD Cowen, Morgan Stanley y RBC Capital, hay una -1.22% downside implícita para Charles River Laboratories International Inc según estas calificaciones más recientes de analistas.
1calculado a partir de las calificaciones de los analistas
El último precio objetivo de Charles River (NYSE:CRL) fue comunicado por TD Cowen el agosto 10, 2026. La firma de analistas fijó un precio objetivo para $300.00 que espera CRL a rise dentro de 12 meses (un posible 0.79% upside). 34 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Charles River (NYSE:CRL) fue proporcionada por TD Cowen, y Charles River mantuvo su buy calificación.
La última revisión al alza de Charles River Laboratories International Inc se produjo en agosto 6, 2026, cuando JP Morgan elevó su precio objetivo a $310. JP Morgan anteriormente tenía a neutral para Charles River Laboratories International Inc.
La última revisión a la baja de Charles River Laboratories International Inc se produjo en julio 20, 2026, cuando CLSA cambió su precio objetivo de $219 a $219 para Charles River Laboratories International Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Charles River, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Charles River se registró el agosto 10, 2026, por lo que la próxima calificación estará disponible en torno al agosto 10, 2027.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Charles River (CRL) fue un mantuvo con un precio objetivo de $235.00 a $300.00. El precio actual al que cotiza Charles River (CRL) es de $297.64, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.
Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas
Datos de mercado proporcionados por APIs de Benzinga
| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 08/10/2026 | Buy Now | 0.79% | TD Cowen | $235 → $300 | Maintains | Buy | Get Alert |
| 08/07/2026 | Buy Now | 0.79% | Morgan Stanley | $260 → $300 | Maintains | Overweight | Get Alert |
| 08/06/2026 | Buy Now | -5.25% | RBC Capital | $215 → $282 | Maintains | Outperform | Get Alert |
| 08/06/2026 | Buy Now | 0.79% | Evercore ISI Group | $260 → $300 | Maintains | Outperform | Get Alert |
| 08/06/2026 | Buy Now | 4.15% | JP Morgan | $180 → $310 | Upgrade | Neutral → Overweight | Get Alert |
| 07/20/2026 | Buy Now | -26.42% | CLSA | $219 → $219 | Downgrade | Outperform → Hold | Get Alert |
| 07/13/2026 | Buy Now | -22.73% | Mizuho | $192 → $230 | Maintains | Neutral | Get Alert |
| 07/09/2026 | Buy Now | -12.65% | Morgan Stanley | $220 → $260 | Maintains | Overweight | Get Alert |
| 06/17/2026 | Buy Now | -26.09% | Morgan Stanley | $185 → $220 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/29/2026 | Buy Now | -26.42% | CLSA | $167 → $219 | Upgrade | Hold → Outperform | Get Alert |
| 05/08/2026 | Buy Now | -26.09% | Barclays | $210 → $220 | Maintains | Overweight | Get Alert |
| 05/08/2026 | Buy Now | -26.09% | Evercore ISI Group | $200 → $220 | Maintains | Outperform | Get Alert |
| 04/14/2026 | Buy Now | -29.44% | Barclays | $200 → $210 | Maintains | Overweight | Get Alert |
| 04/13/2026 | Buy Now | -46.24% | JP Morgan | $165 → $160 | Maintains | Neutral | Get Alert |
| 02/25/2026 | Buy Now | -41.2% | UBS | $170 → $175 | Maintains | Neutral | Get Alert |
| 02/20/2026 | Buy Now | -21.05% | TD Cowen | $251 → $235 | Maintains | Buy | Get Alert |
| 02/20/2026 | Buy Now | -41.2% | Mizuho | $215 → $175 | Maintains | Neutral | Get Alert |
| 02/19/2026 | Buy Now | -32.8% | Barclays | $215 → $200 | Maintains | Overweight | Get Alert |
| 02/19/2026 | Buy Now | -32.8% | Evercore ISI Group | $260 → $200 | Maintains | Outperform | Get Alert |
| 01/16/2026 | Buy Now | -10.97% | Citigroup | $200 → $265 | Maintains | Buy | Get Alert |
| 01/13/2026 | Buy Now | -12.65% | Evercore ISI Group | $250 → $260 | Maintains | Outperform | Get Alert |
| 12/18/2025 | Buy Now | -32.8% | Mizuho | $174 → $200 | Maintains | Neutral | Get Alert |
| 12/15/2025 | Buy Now | -27.77% | Barclays | $210 → $215 | Maintains | Overweight | Get Alert |
| 12/15/2025 | Buy Now | -36.16% | JP Morgan | $165 → $190 | Maintains | Neutral | Get Alert |
| 11/11/2025 | Buy Now | -37.84% | Morgan Stanley | $170 → $185 | Maintains | Equal-Weight | Get Alert |
| 11/10/2025 | Buy Now | -33.81% | TD Cowen | $205 → $197 | Maintains | Buy | Get Alert |
| 11/06/2025 | Buy Now | -44.56% | JP Morgan | $160 → $165 | Maintains | Neutral | Get Alert |
| 11/06/2025 | Buy Now | -29.44% | Barclays | $195 → $210 | Maintains | Overweight | Get Alert |
| 11/06/2025 | Buy Now | -33.14% | Baird | $178 → $199 | Upgrade | Neutral → Outperform | Get Alert |
| 10/17/2025 | Buy Now | -41.54% | Mizuho | $155 → $174 | Maintains | Neutral | Get Alert |
| 10/06/2025 | Buy Now | — | William Blair | — | Upgrade | Market Perform → Outperform | Get Alert |
| 10/03/2025 | Buy Now | -32.8% | Evercore ISI Group | $190 → $200 | Maintains | Outperform | Get Alert |
| 10/02/2025 | Buy Now | -34.48% | Barclays | $165 → $195 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 09/09/2025 | Buy Now | -34.48% | Jefferies | $142 → $195 | Upgrade | Hold → Buy | Get Alert |
| 08/08/2025 | Buy Now | -36.16% | Evercore ISI Group | $180 → $190 | Maintains | Outperform | Get Alert |
| 08/07/2025 | Buy Now | -46.24% | JP Morgan | $145 → $160 | Maintains | Neutral | Get Alert |
| 08/07/2025 | Buy Now | -44.56% | Barclays | $155 → $165 | Maintains | Equal-Weight | Get Alert |
| 07/09/2025 | Buy Now | -39.52% | Evercore ISI Group | $170 → $180 | Maintains | Outperform | Get Alert |
| 07/09/2025 | Buy Now | -32.8% | Citigroup | $150 → $200 | Upgrade | Neutral → Buy | Get Alert |
| 05/23/2025 | Buy Now | -38.85% | Redburn Atlantic | $188 → $182 | Upgrade | Neutral → Buy | Get Alert |
| 05/08/2025 | Buy Now | -47.92% | Barclays | $145 → $155 | Maintains | Equal-Weight | Get Alert |
| 05/08/2025 | Buy Now | -52.96% | Baird | $118 → $140 | Maintains | Neutral | Get Alert |
| 04/10/2025 | Buy Now | -51.28% | Barclays | $160 → $145 | Maintains | Equal-Weight | Get Alert |
| 04/09/2025 | Buy Now | -47.92% | Mizuho | $175 → $155 | Maintains | Neutral | Get Alert |
| 03/21/2025 | Buy Now | -42.88% | Goldman Sachs | $190 → $170 | Downgrade | Buy → Neutral | Get Alert |
| 03/04/2025 | Buy Now | -41.2% | Citigroup | $155 → $175 | Upgrade | Sell → Neutral | Get Alert |
| 03/03/2025 | Buy Now | -36.84% | Redburn Atlantic | $171 → $188 | Upgrade | Sell → Neutral | Get Alert |
| 02/20/2025 | Buy Now | -44.56% | JP Morgan | $175 → $165 | Maintains | Neutral | Get Alert |
| 02/20/2025 | Buy Now | -41.88% | Baird | $177 → $173 | Maintains | Neutral | Get Alert |
| 02/20/2025 | Buy Now | -46.24% | Barclays | $166 → $160 | Maintains | Equal-Weight | Get Alert |
| 02/18/2025 | Buy Now | -44.23% | Barclays | $205 → $166 | Maintains | Equal-Weight | Get Alert |
| 02/05/2025 | Buy Now | -38.18% | Morgan Stanley | $220 → $184 | Maintains | Equal-Weight | Get Alert |
| 02/03/2025 | Buy Now | -41.2% | JP Morgan | $215 → $175 | Maintains | Neutral | Get Alert |
| 01/23/2025 | Buy Now | -36.16% | Goldman Sachs | $220 → $190 | Maintains | Buy | Get Alert |
| 01/22/2025 | Buy Now | — | William Blair | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/17/2025 | Buy Now | -37.84% | UBS | $250 → $185 | Downgrade | Buy → Neutral | Get Alert |
| 01/14/2025 | Buy Now | — | William Blair | — | Reiterates | Outperform → Outperform | Get Alert |
| 12/16/2024 | Buy Now | -26.09% | Morgan Stanley | $225 → $220 | Maintains | Equal-Weight | Get Alert |
| 12/13/2024 | Buy Now | -29.44% | B of A Securities | $220 → $210 | Maintains | Neutral | Get Alert |
| 11/11/2024 | Buy Now | -23.73% | TD Cowen | $203 → $227 | Maintains | Hold | Get Alert |
| 11/07/2024 | Buy Now | -16.01% | UBS | $240 → $250 | Maintains | Buy | Get Alert |
| 11/07/2024 | Buy Now | -24.41% | Evercore ISI Group | $190 → $225 | Maintains | In-Line | Get Alert |
| 10/23/2024 | Buy Now | -43.89% | CLSA | → $167 | Initiates | → Underperform | Get Alert |
| 10/16/2024 | Buy Now | -31.12% | Barclays | $210 → $205 | Maintains | Equal-Weight | Get Alert |
| 10/14/2024 | Buy Now | -49.27% | Redburn Atlantic | → $151 | Initiates | → Sell | Get Alert |
| 10/07/2024 | Buy Now | -36.16% | Evercore ISI Group | $225 → $190 | Downgrade | Outperform → In-Line | Get Alert |
| 10/02/2024 | Buy Now | -27.77% | B of A Securities | $250 → $215 | Downgrade | Buy → Neutral | Get Alert |
| 10/01/2024 | Buy Now | -41.2% | Citigroup | $215 → $175 | Downgrade | Neutral → Sell | Get Alert |
| 09/20/2024 | Buy Now | -36.16% | Baird | $191 → $190 | Maintains | Neutral | Get Alert |
| 08/12/2024 | Buy Now | -31.8% | TD Cowen | $228 → $203 | Maintains | Hold | Get Alert |
| 08/08/2024 | Buy Now | -27.77% | Morgan Stanley | $235 → $215 | Maintains | Equal-Weight | Get Alert |
| 08/08/2024 | Buy Now | -29.44% | Barclays | $230 → $210 | Maintains | Equal-Weight | Get Alert |
| 08/08/2024 | Buy Now | -19.37% | UBS | $290 → $240 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | -24.41% | Evercore ISI Group | $265 → $225 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | -16.01% | Goldman Sachs | $290 → $250 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | -31.12% | JP Morgan | $270 → $205 | Downgrade | Overweight → Neutral | Get Alert |
| 08/08/2024 | Buy Now | -35.83% | Baird | $239 → $191 | Downgrade | Outperform → Neutral | Get Alert |
| 07/10/2024 | Buy Now | -19.7% | Baird | $271 → $239 | Maintains | Outperform | Get Alert |
| 06/28/2024 | Buy Now | -22.73% | Barclays | → $230 | Initiates | → Equal-Weight | Get Alert |
| 06/28/2024 | Buy Now | — | Argus Research | — | Downgrade | Buy → Hold | Get Alert |
| 06/07/2024 | Buy Now | -21.05% | Mizuho | → $235 | Initiates | → Neutral | Get Alert |
| 06/06/2024 | Buy Now | -2.57% | Goldman Sachs | → $290 | Initiates | → Buy | Get Alert |
| 05/13/2024 | Buy Now | -23.4% | TD Cowen | $260 → $228 | Maintains | Hold | Get Alert |
| 05/10/2024 | Buy Now | -9.29% | Baird | $282 → $270 | Maintains | Outperform | Get Alert |
| 03/18/2024 | Buy Now | -2.57% | Argus Research | $240 → $290 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | -5.93% | JP Morgan | $270 → $280 | Maintains | Overweight | Get Alert |
| 02/15/2024 | Buy Now | -10.97% | Evercore ISI Group | $260 → $265 | Maintains | Outperform | Get Alert |
| 02/15/2024 | Buy Now | -2.57% | UBS | $270 → $290 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | -16.01% | Citigroup | $215 → $250 | Maintains | Neutral | Get Alert |
| 02/15/2024 | Buy Now | -9.96% | Baird | $252 → $268 | Maintains | Outperform | Get Alert |
| 02/15/2024 | Buy Now | — | Guggenheim | — | Downgrade | Buy → Neutral | Get Alert |
| 12/20/2023 | Buy Now | -9.29% | JP Morgan | $210 → $270 | Maintains | Overweight | Get Alert |
| 12/11/2023 | Buy Now | -27.77% | Citigroup | $190 → $215 | Maintains | Neutral | Get Alert |
| 11/10/2023 | Buy Now | -31.12% | Morgan Stanley | $220 → $205 | Maintains | Equal-Weight | Get Alert |
| 11/09/2023 | Buy Now | -27.77% | UBS | $250 → $215 | Maintains | Buy | Get Alert |
| 10/24/2023 | Buy Now | -26.09% | Morgan Stanley | $235 → $220 | Maintains | Equal-Weight | Get Alert |
| 09/25/2023 | Buy Now | -29.78% | TD Cowen | $212 → $209 | Maintains | Market Perform | Get Alert |
| 09/22/2023 | Buy Now | -13.99% | Baird | $267 → $256 | Maintains | Outperform | Get Alert |
| 09/22/2023 | Buy Now | -24.41% | Guggenheim | $255 → $225 | Maintains | Buy | Get Alert |
| 09/22/2023 | Buy Now | -7.61% | Wells Fargo | $280 → $275 | Maintains | Overweight | Get Alert |